Show simple item record

dc.contributor.authorSarmadi, Morteza
dc.contributor.authorBehrens, Adam M
dc.contributor.authorMcHugh, Kevin J
dc.contributor.authorContreras, Hannah TM
dc.contributor.authorTochka, Zachary L
dc.contributor.authorLu, Xueguang
dc.contributor.authorLanger, Robert S
dc.contributor.authorJaklenec, Ana
dc.date.accessioned2022-07-14T17:52:11Z
dc.date.available2021-10-27T20:23:17Z
dc.date.available2022-07-14T17:52:11Z
dc.date.issued2020
dc.identifier.urihttps://hdl.handle.net/1721.1/135398.2
dc.description.abstractInefficient injection of microparticles through conventional hypodermic needles can impose serious challenges on clinical translation of biopharmaceutical drugs and microparticle-based drug formulations. This study aims to determine the important factors affecting microparticle injectability and establish a predictive framework using computational fluid dynamics, design of experiments, and machine learning. A numerical multiphysics model was developed to examine microparticle flow and needle blockage in a syringe-needle system. Using experimental data, a simple empirical mathematical model was introduced. Results from injection experiments were subsequently incorporated into an artificial neural network to establish a predictive framework for injectability. Last, simulations and experimental results contributed to the design of a syringe that maximizes injectability in vitro and in vivo. The custom injection system enabled a sixfold increase in injectability of large microparticles compared to a commercial syringe. This study highlights the importance of the proposed framework for optimal injection of microparticle-based drugs by parenteral routes.en_US
dc.language.isoen
dc.publisherAmerican Association for the Advancement of Science (AAAS)en_US
dc.relation.isversionof10.1126/SCIADV.ABB6594en_US
dc.rightsCreative Commons Attribution NonCommercial License 4.0en_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/en_US
dc.sourceScience Advancesen_US
dc.titleModeling, design, and machine learning-based framework for optimal injectability of microparticle-based drug formulationsen_US
dc.typeArticleen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Mechanical Engineeringen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.contributor.departmentHarvard University--MIT Division of Health Sciences and Technologyen_US
dc.contributor.departmentMassachusetts Institute of Technology. Institute for Medical Engineering & Scienceen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.relation.journalScience Advancesen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2021-06-22T15:46:16Z
dspace.orderedauthorsSarmadi, M; Behrens, AM; McHugh, KJ; Contreras, HTM; Tochka, ZL; Lu, X; Langer, R; Jaklenec, Aen_US
dspace.date.submission2021-06-22T15:46:18Z
mit.journal.volume6en_US
mit.journal.issue28en_US
mit.licensePUBLISHER_CC
mit.metadata.statusPublication Information Neededen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

VersionItemDateSummary

*Selected version